课题基金 / 基金详情

YOGURT DRINK CONTAINING BIFIDOBACTERIUM LACTIS (BB12) FUNCTIONAL GASTROINTESTINL

YOGURT DRINK CONTAINING BIFIDOBACTERIUM LACTIS (BB12) FUNCTIONAL GASTROINTESTINL
含有乳双歧杆菌 (BB12) 功能性胃肠测试的酸奶饮料
批准号:
7716904
负责人:
YEHUDA RINGEL
金额:
$2.01万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-02 至 2008-05-31

项目摘要

项目成果

YEHUDA RINGEL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Purpose: To assess the clinical benefit of oral consumption of yogurt drink containing probiotic bacteria (bifidobacterium lactis BB12) on gastrointestinal function and symptoms in non-patients subjects with the functional bowel symptoms. Participants: men and women of all races and ethnicity between the ages of 18 and 70 years old. Procedures (methods): This is a 6-week probiotic food supplement, prospective, randomized, double blinded, placebo controlled study to evaluate the efficacy of a yogurt drink containing probiotic bacteria BB12 in non-patients with functional GI symptoms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Fecal Microflora in Irritable Bowel Syndrome: Characterization & Significance
Fecal Microflora in Irritable Bowel Syndrome (IBS): Characterization and Signific
CLINICAL TRIAL: PROBIOTIC BACTERIA IN PATIENTS WITH IBS, FUNCTIONAL DIARRHEA, OR
The Role of Intestinal Inflammation in the Pathophysiology of IBS
国内基金
海外基金
Segmented Filamentous Bacteria激活宿主免疫系统抑制其拮抗菌 Enterobacteriaceae维持菌群平衡及其机制研究
  • 批准号:
    81971557
  • 项目类别:
    面上项目
  • 资助金额:
    65.0万元
  • 批准年份:
    2019
  • 负责人:
    毛开睿
  • 依托单位:
电缆细菌(Cable bacteria)对水体沉积物有机污染的响应与调控机制